Illinois CancerCare- Peru is a clinical research site located in Peru, Illinois, United States 61354.
Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.
Illinois CancerCare- Peru has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Leukemia.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Alliance for Clinical Trials in Oncology.
Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Illinois CancerCare- Peru has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Illinois CancerCare- Peru has 2 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Leukemia.
Illinois CancerCare- Peru has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.